NEET-PG 2013 - Biochemistry Practice Questions

Q: Kcat/Km is a measure of which of the following?

Enzyme efficiency. **Correct: Enzyme efficiency** - The ratio **kcat/Km** is the definitive measure of an enzyme's **catalytic efficiency** or **specificity constant** - It reflects how effectively an enzyme converts substrate to product at low substrate concentrations - A higher **kcat/Km** value indicates greater efficiency, combining high catalytic rate (kcat) with strong substrate affinity (low Km) - This is the most important parameter for comparing different enzymes or different substrates for the same enzyme *Incorrect: Speed of enzymatic reaction* - **kcat** (turnover number) alone measures the maximum speed when enzyme is saturated with substrate - **kcat/Km** is a more comprehensive measure that includes substrate binding affinity, not just reaction speed - Speed also depends on enzyme and substrate concentrations, which kcat/Km doesn't directly represent *Incorrect: Concentration of substrate* - **Km** (Michaelis constant) represents the substrate concentration at which reaction velocity is half of Vmax - **kcat/Km** is a ratio that describes enzyme performance across substrate concentrations, not the concentration itself - It's particularly useful for predicting enzyme behavior at physiological (low) substrate concentrations *Incorrect: Enzyme turnover* - **kcat** specifically measures enzyme turnover: the number of substrate molecules converted per enzyme molecule per unit time at saturation - **kcat/Km** incorporates both kcat and Km, providing overall efficiency rather than just turnover rate - Turnover is only one component of the efficiency measure

Q: Which transporter is responsible for the transport of glucose in the pancreas?

GLUT 2. ***GLUT 2*** - **GLUT2** is a **low-affinity, high-capacity** glucose transporter primarily found in the **pancreatic beta cells**, liver, small intestine, and kidneys. - In pancreatic beta cells, GLUT2 allows rapid entry of glucose for metabolism, leading to **insulin secretion** in response to elevated blood glucose levels. *GLUT 1* - **GLUT1** is a **ubiquitous glucose transporter** found in most tissues, including red blood cells and the blood-brain barrier. - It has a high affinity for glucose, ensuring **basal glucose uptake** even at low concentrations. *GLUT 3* - **GLUT3** is a **high-affinity glucose transporter** concentrated in **neurons** and the brain. - Its efficient glucose uptake is critical for the constant and high energy demands of the central nervous system. *GLUT 4* - **GLUT4** is an **insulin-dependent glucose transporter** primarily found in **adipose tissue** and **striated muscle (skeletal and cardiac muscle)**. - Insulin stimulates the translocation of GLUT4 to the cell membrane, facilitating glucose uptake from the blood after a meal.

Q: Inhibition of glycolysis by increased supply of O2 is called ?

Pasteur effect. ***Pasteur effect*** - The **Pasteur effect** describes the phenomenon where the rate of **glycolysis** is inhibited when **oxygen** is available (aerobic conditions). - This inhibition occurs because **oxidative phosphorylation** is more efficient at generating ATP, leading to reduced reliance on glycolysis for energy production. *Crabtree phenomenon* - The **Crabtree phenomenon** is the opposite of the Pasteur effect, where high concentrations of **glucose** inhibit oxygen consumption in the presence of oxygen. - This is primarily observed in some **cancer cells** and yeast, leading to increased glycolysis even under aerobic conditions. *Lewis phenomenon* - The **Lewis phenomenon** (also known as the hunting reaction) refers to the cyclical vasodilation and constriction of peripheral blood vessels in response to **cold exposure**. - It's a physiological response to protect tissues from **frostbite** and is not related to glycolysis or oxygen supply. *None of the options* - This option is incorrect as the phenomenon described, inhibition of glycolysis by increased O2, is a well-established biochemical process known as the **Pasteur effect**.

Q: Which of the following is not a phospholipid ?

Ganglioside. ***Ganglioside*** - Gangliosides are a type of **glycosphingolipid** because their structure includes a ceramide (a sphingoid base linked to a fatty acid) and a carbohydrate portion with one or more **sialic acid** residues, but no phosphate group. - They are primarily found in **nerve cell membranes** and are crucial for cell-cell recognition and signaling, differentiating them from phospholipids which contain a phosphate group. *Lecithin* - Lecithin, specifically **phosphatidylcholine**, is a common phospholipid characterized by a **phosphate group** and a **choline head group** attached to a diacylglycerol backbone. - It plays vital roles in cell membrane structure and function and is an important emulsifier. *Plasmalogen* - Plasmalogens are a class of phospholipids characterized by a **vinyl ether linkage** at the *sn*-1 position of the glycerol backbone, instead of the typical ester linkage found in other phospholipids. - They retain the defining **phosphate group** that classifies them as phospholipids. *Cardiolipin* - Cardiolipin is a unique phospholipid composed of **two phosphatidic acid moieties** connected by a glycerol molecule, resulting in four fatty acid chains and two phosphate groups. - It is predominantly found in the **inner mitochondrial membrane**, essential for mitochondrial function.

Q: Ketone bodies are not used by?

RBC. ***RBC*** - Red blood cells **lack mitochondria**, which are essential organelles for the **oxidation of ketone bodies** (acetoacetate and β-hydroxybutyrate) for energy production. - Their primary energy source is **anaerobic glycolysis** of glucose. *Muscle* - **Skeletal and cardiac muscles** readily utilize **ketone bodies** as an alternative fuel source, especially during prolonged fasting or starvation. - This helps to conserve glucose for other tissues, particularly the brain. *Brain* - The brain can adapt to use **ketone bodies** for energy when glucose supply is limited, such as during prolonged fasting or in cases of uncontrolled diabetes. - This process is crucial for brain function when glucose levels are low. *Renal cortex* - The **renal cortex** is capable of utilizing **ketone bodies** for energy, particularly during starvation. - The kidney is also involved in the **synthesis of glucose** (gluconeogenesis) and the excretion of ketone bodies.

Q: Ketone body formation without glycosuria is seen in ?

Starvation. ***Starvation*** - During **starvation**, the body depletes its **glycogen stores** and begins to break down **fat for energy**. This process leads to the production of **ketone bodies** (acetoacetate, beta-hydroxybutyrate, and acetone) as an alternative fuel source for the brain and other tissues. - Since there is no underlying problem with **insulin production** or action, blood glucose levels are typically low or normal, and therefore, **glycosuria** (glucose in the urine) is absent. *Diabetes mellitus* - In **uncontrolled diabetes mellitus**, especially Type 1, the body cannot effectively use **glucose** due to lack of insulin, leading to high blood glucose levels (**hyperglycemia**) and subsequently **glycosuria**. - The body then compensates by breaking down **fats**, leading to the formation of **ketone bodies** (**diabetic ketoacidosis**), which results in both **ketonuria** and **glycosuria**. *Diabetes insipidus* - **Diabetes insipidus** is a condition characterized by the inability to conserve water due to insufficient **antidiuretic hormone (ADH)** production or action, leading to excessive urination and thirst. - It does not involve abnormalities in **glucose metabolism** or **ketone body production** and therefore does not typically present with ketonuria or glycosuria. *Obesity* - While **obesity** can lead to **insulin resistance** and is a risk factor for Type 2 Diabetes, it does not directly cause **ketone body formation** in the absence of metabolic derangements such as those seen in uncontrolled diabetes or prolonged starvation. - In most cases of obesity without diabetes, **glucose metabolism** is still adequate enough to prevent significant reliance on **fat breakdown** for energy, meaning there is usually no ketonuria or glycosuria.

Q: What is essential for the transfer of fatty acid across the mitochondrial membrane?

Carnitine. ***Carnitine*** - **Carnitine** is crucial for transporting **long-chain fatty acids** into the mitochondrial matrix for **beta-oxidation**. - It forms **acylcarnitine** by esterifying with fatty acids, allowing passage through the inner mitochondrial membrane via the **carnitine-acylcarnitine translocase**. *Creatinine* - **Creatinine** is a waste product formed from the breakdown of **creatine phosphate** in muscles and is excreted by the kidneys. - It serves as a marker for **kidney function** and has no role in fatty acid transport. *Biotin* - **Biotin** is a vitamin cofactor essential for **carboxylase enzymes**, including acetyl-CoA carboxylase in **fatty acid synthesis**. - While involved in lipid metabolism, it plays no role in the transport of fatty acids across mitochondrial membranes. *Creatine* - **Creatine** is a nitrogenous organic acid that helps supply energy to cells, primarily muscle, by facilitating the regeneration of **ATP**. - It plays no direct role in the facilitated transport of fatty acids across the mitochondrial membrane.

Q: Krabbe's disease is due to deficiency of ?

Beta galactocerebrosidase. ***Beta galactocerebrosidase*** - Krabbe's disease is specifically caused by a deficiency of **beta-galactocerebrosidase**, leading to the accumulation of toxic substances in the brain [1]. - This disease predominantly affects the **myelin sheath**, resulting in severe neurological deterioration [1]. *Arylsulfatase* - Deficiency of **arylsulfatase** is associated with **metachromatic leukodystrophy**, not Krabbe's disease. - Symptoms and pathology differ significantly, primarily affecting **sulfatides** rather than galactocerebrosides. *Sphingomyelinase* - A deficiency of **sphingomyelinase** is linked to **Niemann-Pick disease**, characterized by splenomegaly and liver involvement. - This condition does not involve the same neurological deterioration seen in Krabbe's disease. *Hexosaminidase* - Hexosaminidase deficiency is associated with **Tay-Sachs disease**, primarily affecting the **GM2 gangliosides** [2]. - This results in different clinical manifestations, such as **cherry-red spots** and progressive neurodegeneration, rather than the symptoms of Krabbe's disease [2]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1304-1305. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Genetic Disorders, p. 161.

Q: Which of the following lipoproteins is most strongly associated with an increased risk of cardiovascular diseases and is commonly referred to as "bad cholesterol"?

LDL. ***LDL*** - **Low-density lipoprotein (LDL)** is commonly referred to as "bad" cholesterol because elevated levels are the **primary driver** of atherosclerotic plaque buildup in arterial walls. - LDL particles transport cholesterol from the liver to peripheral tissues; when present in excess, they infiltrate the arterial intima and undergo oxidative modification, triggering inflammatory responses that lead to atherosclerosis. - **Clinical significance:** LDL cholesterol is the primary target of lipid-lowering therapy in cardiovascular disease prevention. *VLDL* - **Very low-density lipoprotein (VLDL)** primarily transports endogenously synthesized **triglycerides** from the liver to peripheral tissues. - While elevated VLDL levels do contribute to cardiovascular risk (particularly through conversion to small, dense LDL particles), it is not the primary lipoprotein targeted in cardiovascular risk assessment. *Chylomicron* - **Chylomicrons** transport **dietary lipids** (triglycerides and cholesterol) from the intestines to tissues after meals. - They are rapidly cleared from circulation (half-life of 5-10 minutes) and are typically not present during fasting, making their contribution to chronic atherosclerotic plaque formation minimal. *Lp(a)* - **Lipoprotein(a) [Lp(a)]** is structurally similar to LDL but contains an additional apolipoprotein(a) molecule, which has homology to plasminogen and may interfere with fibrinolysis. - While Lp(a) is an independent cardiovascular risk factor, it is less commonly measured in routine clinical practice, and **LDL remains the cornerstone lipoprotein** for cardiovascular risk stratification and management.

Q: Which kinetic parameter is primarily associated with enzyme specificity?

None of the options. ***None of the options*** - **Enzyme specificity** is primarily determined by the unique three-dimensional **active site structure** of the enzyme, which allows it to bind only to specific substrates through complementary shape and chemical interactions. - This structural complementarity involves steric fit and specific non-covalent interactions (hydrogen bonds, van der Waals forces, electrostatic interactions) between the enzyme and its substrate. - **Neither Km nor Vmax are determinants of enzyme specificity**—they are kinetic parameters that describe enzyme behavior, not structural selectivity. *Km (Michaelis constant)* - Represents the substrate concentration at which the reaction rate is half of Vmax. - Indicates the **affinity** of an enzyme for its substrate (lower Km = higher affinity). - While enzymes may show different Km values for different substrates, **Km reflects binding affinity, not the structural basis of specificity**. *Vmax (Maximum velocity)* - The maximum rate of reaction when the enzyme is saturated with substrate. - Reflects **catalytic efficiency** and the amount of active enzyme present. - Does not relate to the enzyme's ability to discriminate between different substrate molecules. *Both* - Incorrect because neither Km nor Vmax determines which substrates an enzyme can recognize and bind. - Enzyme specificity is a **structural property** of the active site, while Km and Vmax are **kinetic properties** that describe reaction rates.

Question 1

Kcat/Km is a measure of which of the following?

Accepted Answer

Enzyme efficiency

Answer

Speed of enzymatic reaction

Answer

Concentration of substrate

Answer

Enzyme turnover

Question 2

Which transporter is responsible for the transport of glucose in the pancreas?

Accepted Answer

GLUT 2

Answer

GLUT 1

Answer

GLUT 3

Answer

GLUT 4

Question 3

Inhibition of glycolysis by increased supply of O2 is called ?

Accepted Answer

Pasteur effect

Answer

Crabtree phenomenon

Answer

Lewis phenomenon

Answer

None of the options

Question 4

Which of the following is not a phospholipid ?

Accepted Answer

Ganglioside

Answer

Lecithin

Answer

Plasmalogen

Answer

Cardiolipin

Question 5

Ketone bodies are not used by?

Accepted Answer

RBC

Answer

Brain

Answer

Muscle

Answer

Renal cortex

Question 6

Ketone body formation without glycosuria is seen in ?

Accepted Answer

Starvation

Answer

Diabetes mellitus

Answer

Diabetes insipidus

Answer

Obesity

Question 7

What is essential for the transfer of fatty acid across the mitochondrial membrane?

Accepted Answer

Carnitine

Answer

Creatinine

Answer

Biotin

Answer

Creatine

Question 8

Krabbe's disease is due to deficiency of ?

Accepted Answer

Beta galactocerebrosidase

Answer

Sphingomyelinase

Answer

Hexosaminidase

Answer

Arylsulfatase

Question 9

Which of the following lipoproteins is most strongly associated with an increased risk of cardiovascular diseases and is commonly referred to as "bad cholesterol"?

Accepted Answer

LDL

Answer

VLDL

Answer

Chylomicron

Answer

Lp (a)

Question 10

Which kinetic parameter is primarily associated with enzyme specificity?

Accepted Answer

None of the options

Answer

Both

Answer

Km

Answer

Vmax

NEET-PG 2013 — Biochemistry